FDA
approval
· 2026-03-27
FDA Approved: ESCITALOPRAM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
Summary
FDA approved Lupin Pharmaceuticals' supplemental application for a generic escitalopram product (ANDA 078169).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ESCITALOPRAM (ESCITSLOPRAM)